Preserving ovarian function in patients receiving cyclophosphamide

Lupus. 1999;8(1):3-10. doi: 10.1191/096120399678847335.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Amenorrhea / chemically induced
  • Bone Density / drug effects
  • Cyclophosphamide / adverse effects*
  • Female
  • Gonadotropin-Releasing Hormone / physiology
  • Humans
  • Leuprolide / adverse effects
  • Leuprolide / pharmacology
  • Ovary / drug effects*
  • Ovary / physiology

Substances

  • Gonadotropin-Releasing Hormone
  • Cyclophosphamide
  • Leuprolide